Lever Western Massachusetts HealthTech Challenge

The Western Massachusetts Health Technology Challenge will accelerate up to eight early-stage companies operating in Berkshire, Franklin, Hampden or Hampshire Counties. Finalists will participate in acceleration workshops, work with expert mentors, and pitch their concepts at a final pitch event. Expert judges will award a $50,000 Innovation Grant to the top team, and a $25,000 Innovation Grant to the runner-up.

Friday, March 3, 2023
1:00-4:00 pm

Pitches: 1pm - 2:45pm
Reception: 2:45pm - 4pm
Winner Announced: 3:30pm

LSL S330-340

The challenge is funded in part by the Massachusetts Life Sciences Center, an economic development investment agency dedicated to supporting the growth and development of the life sciences in Massachusetts.

Five UMass Amherst startups will be featured!

• Quaesar Therapeutics - Anujan Ramesh
  Quaesar Therapeutics has developed a non-invasive blood-based diagnostic test that can detect the incidence and spread of ovarian cancer significantly earlier compared to clinical standards.
• Latde Diagnostics - Emily Melzer
  Latde Diagnostics is developing a rapid, low-cost, test to determine antibiotic susceptibility for bloodborne pathogens.
• To Be Named - Govind Srimathveeralli
  Srimathveerali’s team has technology to generate on-demand liquid biopsy samples to support rapid diagnosis.
• Baystate Health - Anant Shinde
  Baystate Health is developing a high-dose non-invasive brain stimulator to expand the capabilities of clinical MRI studies. MRI setting.
• MacFarlane Medical - Connor MacFarlane
  MacFarlane Medical’s Improved Insulin Delivery (IID) port is easy to use, discrete, waterproof, and most importantly, convenient and reliable, giving diabetic patients increased comfort and freedom